GENOTOXICITY OF BLEOMYCIN

被引：223

作者：

POVIRK, LF

AUSTIN, MJF

机构：

[1] Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond

来源：

MUTATION RESEARCH | 1991年 / 257卷 / 02期

关键词：

BLEOMYCIN; GENOTOXICITY; BLENOXANE;

D O I：

10.1016/0165-1110(91)90022-N

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：127 / 143

页数：17

共 123 条

[1]

ABE T, 1985, CANCER TREAT REP, V69, P505

[2]

ADLER ID, 1983, TERATOGEN CARCIN MUT, V3, P321, DOI 10.1002/1520-6866(1990)3:4<321::AID-TCM1770030403>3.0.CO

[3]

2-2

[4] BLEOMYCIN-RESISTANT CELLS CONTAIN INCREASED BLEOMYCIN-HYDROLASE ACTIVITIES [J].

AKIYAMA, S ;

IKEZAKI, K ;

KURAMOCHI, H ;

TAKAHASHI, K ;

KUWANO, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (01) :55-60

[5]

ALBERTS DS, 1979, CANCER CHEMOTH PHARM, V3, P33

[6]

AUSTIN MJF, 1989, AM J HUM GENET, V45, pA100

[7]

BANERJEE A, 1979, CANCER RES, V39, P797

[8] ASSESSMENT OF PREFERENTIAL CLEAVAGE OF AN ACTIVELY TRANSCRIBED RETROVIRAL HYBRID GENE IN MURINE CELLS BY DEOXYRIBONUCLEASE-I, BLEOMYCIN, NEOCARZINOSTATIN, OR IONIZING-RADIATION [J].

BECKMANN, RP ;

AGOSTINO, MJ ;

MCHUGH, MM ;

SIGMUND, RD ;

BEERMAN, TA .

BIOCHEMISTRY, 1987, 26 (17) :5409-5415

[9]

BONODONNA G, 1989, RECENT RESULTS CANC, V117, P169

[10]

BOORSTEIN RJ, 1988, CANCER RES, V48, P5466

← 1 2 3 4 5 6 7 8 9 10 →